≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other specific arthropathies

DOID Endpoint Browser PheWeb

M13_OTERSPECARTHR

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M12.8
  • Hospital discharge: ICD-9 — 7164
  • Cause of death: ICD-10 — M12.8
  • Cause of death: ICD-9 — 7164

2 out of 7 registries used, show all original rules.

71

4. Check minimum number of events

None

71

5. Include endpoints

None

71

6. Filter based on genotype QC (FinnGen only)

71

Control definitions (FinnGen only)

Control exclude
M13_ARTHROPATHIES

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M12
Name in latin
Aliae arthropathiae specificae non alibi classificatae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 538 264 268
Only index persons 487 239 248
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 43.11 48.62 37.31
Only index persons 39.19 46.04 32.59

-FinnGen-

Key figures

All Female Male
Number of individuals 71 40 31
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 45.98 46.23 45.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
66
Matched controls
661
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M12.8
ICD-10 Finland
Other specific arthropathies, not elsewhere classified
+∞
67.8
53
*
7164A
ICD-9 Finland
Other and unspecified arthropathies, Transient arthropathy
+∞
14.0
13
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
24.0
12.9
18
10
M19.0
ICD-10 Finland
Primary arthrosis of other joints
79.2
12.1
13
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
24.8
10.3
14
7
A07EC01
ATC
sulfasalazine; oral, rectal
24.8
10.3
14
7
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
17.1
9.7
15
11
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
+∞
9.6
9
*
M13.9
ICD-10 Finland
Arthritis, unspecified
19.7
9.0
13
8
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
102.3
8.6
9
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
102.3
8.6
9
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
102.3
8.6
9
*
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
38.5
8.3
10
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
25.8
8.3
11
5
M25.5
ICD-10 Finland
Pain in joint
6.3
8.1
23
51
P01BA02
ATC
hydroxychloroquine; oral
21.5
7.9
11
6
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
+∞
7.4
7
*
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
+∞
7.4
7
*
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
34.0
7.3
9
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
76.7
6.5
7
*
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
29.7
6.4
8
*
L88
ICPC
Rheumatoid/seropositive arthritis
29.7
6.4
8
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
11.7
6.3
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037522) Nuclear Ab [Titer] in Serum
21
50
5.54
8.92
1.6
1.4
titre
448.0
280.0
—
5
7
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
24
74
4.39
7.38
1.2
1.2
u/ml
34.2
1.2
—
8
36
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
69
4.45
7.32
1.2
1.3
iu/ml
16.9
13.3
—
7
22
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
9
15
6.70
3.96
1.1
1.2
g/l
0.3
0.3
—
9
15
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
9
16
6.27
3.79
1.1
1.2
g/l
1.3
1.2
—
9
16
(36660697) Celiac disease serology panel - Serum
13
42
3.56
3.58
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
14
6.28
3.45
1.4
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
30
169
2.34
2.95
9.8
4.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
10
31
3.59
2.89
7.4
4.0
mmol/l
2.0
1.0
—
5
25
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
11
5.84
2.60
1.2
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
50
362
2.29
2.57
5.8
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
24
131
2.26
2.48
11.6
7.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
8
26
3.33
2.08
6.4
3.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
11
45
2.71
2.04
6.5
1.6
g/l
9.7
9.8
0.02
11
40
(3013512) EKG study
24
143
2.02
1.94
4.0
3.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
37
262
1.86
1.77
3.3
3.1
estimate
0.0
0.0
—
5
47
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
37
262
1.86
1.77
7.9
7.4
mmol/l
1.2
1.2
0.15
29
213
(3022145) Colonoscopy Study observation
12
57
2.33
1.66
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
14
3.76
1.64
1.2
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
20
3.18
1.62
2.8
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
20
3.18
1.62
2.5
2.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
111
1.97
1.59
3.3
2.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
34
241
1.79
1.57
5.9
5.4
mmol/l
1.2
1.2
0.01
29
222
(3008898) HLA-B27 [Presence]
5
15
3.50
1.55
1.2
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
5
15
3.50
1.55
2.0
1.2
nmol/l
28.4
37.3
—
5
15
(3045414) Leukocytes [Presence] in Urine
6
21
3.02
1.54
2.7
2.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
28
189
1.80
1.51
2.1
1.9
pmol/l
85.6
97.6
0.95
15
94
(3015736) pH of Urine
29
198
1.79
1.51
2.6
2.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
24
155
1.83
1.49
4.1
1.9
u/l
128.6
139.4
0.14
24
148
(3012516) Albumin [Mass/volume] in Urine
23
151
1.77
1.34
3.2
3.2
mg/l
238.1
486.7
0.23
15
97
(3000330) Specific gravity of Urine by Test strip
6
24
2.63
1.33
3.2
4.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
35
260
1.68
1.31
4.6
4.2
estimate
0.0
0.0
—
5
46
(3019225) pH of Specimen
10
49
2.21
1.29
4.9
5.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
27
191
1.67
1.20
7.0
8.2
inr
1.3
1.2
—
5
55
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
26
183
1.66
1.17
5.2
3.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
62
554
1.94
1.16
16.7
11.4
ml/min/173m2
79.9
84.4
0.80
57
456
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
41
2.07
1.13
1.4
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
46
2.09
1.09
2.4
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
61
1.95
1.05
1.8
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
15
93
1.78
1.04
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
35
2.11
1.03
1.7
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
46
382
1.58
1.00
3.1
3.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
51
1.87
0.99
1.8
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
28
2.25
0.94
2.3
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
22
159
1.56
0.86
4.8
4.1
mg/mmol
46.9
8.5
0.64
14
102
(40761535) Cells panel - Urine sediment
8
47
1.79
0.84
5.1
3.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
20
143
1.55
0.82
4.0
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
27
207
1.49
0.81
3.7
3.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
12
76
1.70
0.77
3.4
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
56
1.69
0.76
2.0
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
30
238
1.45
0.75
3.4
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
9
57
1.66
0.74
1.2
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
24
183
1.47
0.73
4.6
3.2
e6/l
13.5
234.9
0.60
18
122
(3023368) Bacteria identified in Blood by Culture
18
129
1.53
0.73
5.9
3.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
17
123
1.50
0.66
2.2
1.5
g/l
1.9
2.4
—
8
74
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
29
1.78
0.65
3.6
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
64
597
1.73
0.64
20.7
13.9
mmol/l
4.0
4.0
0.01
64
582
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
23
0.00
0.59
0.0
1.6
—
330.7
—
0
15
(3022621) pH of Urine by Test strip
6
36
1.73
0.58
2.7
2.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
29
238
1.37
0.57
1.7
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
37
1.68
0.57
1.8
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
75
1.55
0.54
1.4
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
20
157
1.38
0.51
2.9
2.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
37
419
0.76
0.50
4.2
2.7
u/l
51.7
48.5
0.11
37
396
(3017143) Hepatitis C virus Ab [Presence] in Serum
10
69
1.52
0.47
1.2
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
8
60
1.38
0.42
1.8
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
16
0.00
0.41
0.0
2.8
—
134.5
—
0
10
(3019060) Gas panel - Arterial blood
5
34
1.51
0.41
2.6
5.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
63
596
1.51
0.41
20.9
13.8
mmol/l
139.4
139.8
0.48
63
580
(3026008) Bacteria identified in Urine by Culture
18
144
1.33
0.40
3.3
3.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
77
0.62
0.38
1.0
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
42
1.47
0.36
1.7
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
65
621
1.55
0.35
18.8
11.5
—
—
—
0
0
(3000492) Spirometry study
6
45
1.36
0.35
4.3
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
8
61
1.35
0.29
1.8
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
8
64
1.28
0.29
2.0
2.0
umol/l
4.3
6.4
—
8
54
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
8
65
1.26
0.28
7.9
6.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
9
72
1.29
0.27
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
39
1.30
0.23
1.8
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
39
1.30
0.23
1.0
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8
103
0.75
0.23
1.5
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
10
0.00
0.21
0.0
3.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
57
1.25
0.19
3.3
3.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
65
0.75
0.18
1.0
2.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
56
540
1.18
0.16
19.2
12.9
%
38.4
40.4
0.62
43
400
(40760892) CBC W Ordered Manual Differential panel - Blood
14
124
1.16
0.12
3.2
4.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
86
1.19
0.11
1.8
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
43
1.17
0.10
1.8
1.4
—
—
—
0
0
(3012544) pH of Venous blood
5
45
1.12
0.10
3.0
4.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
13
117
1.14
0.09
2.5
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
14
127
1.13
0.08
3.9
4.5
%
23.1
20.8
—
9
60
(3044889) 12 lead EKG panel
41
401
1.05
0.03
3.7
3.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
16
162
0.98
0.00
2.3
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
19
188
1.01
0.00
2.6
2.2
u/l
55.5
55.1
0.02
19
173
(1761868) Lipid panel - Serum or Plasma
23
229
1.01
0.00
3.0
3.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
16
156
1.03
0.00
1.2
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(4062490)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44790049)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44790048)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
20.3
—
1743.4
—
0
7
(3019230) Fractional oxyhemoglobin in Venous blood
0
7
0.00
0.00
0.0
3.0
—
65.1
—
0
7
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
2.7
—
0
7
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790047)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
0.8
—
0
5
(21494755) Public health laboratory ask at order entry panel
8
79
1.01
0.00
1.1
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
3.9
—
165.7
—
0
9
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(44806118)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
6
59
1.02
0.00
2.3
1.9
u/l
120.8
33.8
—
6
46
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
17.6
—
960.6
—
0
7
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
11.9
—
0
9
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
1.9
—
13.7
—
0
7
(3011648) Oxygen content in Venous blood
0
5
0.00
0.00
0.0
1.8
—
14.7
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint M13_OTERSPECARTHR and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_OTERSPECARTHR.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: M13_OTERSPECARTHR – Other specific arthropathies

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data